SCHEMBL765738

SCHEMBL765738

NC(=O)c1ccc(F)c(C(F)F)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 5/20 0.47
CES2 O00748 1/20 0.42
CES1 P23141 1/20 0.42
ERN1 O75460 2/20 0.41
LCK P06239 1/20 0.41
AR P10275 1/20 0.41
TSHR P16473 1/20 0.39
PARP10 Q53GL7 3/20 0.39
PARP15 Q460N3 2/20 0.38
PARP14 Q460N5 2/20 0.38
ALDH1A1 P00352 1/20 0.38
KMT2A Q03164 1/20 0.38
PARP16 Q8N5Y8 1/20 0.38
PARP11 Q9NR21 1/20 0.38
PARP4 Q9UKK3 1/20 0.38
ACLY P53396 1/20 0.38
MAPK1 P28482 1/20 0.38
HTR5A P47898 1/20 0.37
TNKS O95271 1/20 0.37
TNKS2 Q9H2K2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3691250 0.85 SLC9A1 (0.45) PARP1CES2CES1ERN1LCK
SCHEMBL18451256 0.83 PARP1 (0.43) PARP1CES2CES1ERN1LCK
SCHEMBL18451253 0.83 PARP1 (0.43) PARP1CES2CES1ERN1LCK
SCHEMBL30147535 0.82 LMNA (0.47) CES2CES1ERN1TSHRKMT2A
SCHEMBL26263149 0.82 LMNA (0.47) CES2CES1ERN1TSHRKMT2A
SCHEMBL31085117 0.80 CES2 (0.42) CES2CES1ALDH1A1
SCHEMBL289633 0.79 CES2 (0.67) PARP1CES2CES1ERN1LCK
SCHEMBL29781365 0.79 CES2 (0.67) PARP1CES2CES1ERN1LCK
SCHEMBL27326910 0.78 MAPK1 (0.41) PARP1ERN1ARPARP10ALDH1A1
SCHEMBL31188464 0.77 CES2 (0.64) PARP1CES2CES1ERN1LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1954668-B9 HOMO- AND HETEROCYCLIC COMPOUNDS SUITABLE AS CETP INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2012-03-21 EP disclosed
EP-1954668-B1 HOMO- AND HETEROCYCLIC COMPOUNDS SUITABLE AS CETP INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2011-09-28 EP disclosed